Suppr超能文献

影响结直肠癌肝转移肝切除术后手术切缘复发的因素。

Factors affecting surgical margin recurrence after hepatectomy for colorectal liver metastases.

作者信息

Akyuz Muhammet, Aucejo Federico, Quintini Cristiano, Miller Charles, Fung John, Berber Eren

机构信息

Department of General Surgery, Cleveland Clinic, Cleveland, Ohio, USA.

出版信息

Gland Surg. 2016 Jun;5(3):263-9. doi: 10.21037/gs.2015.12.03.

Abstract

BACKGROUND

Hepatic recurrence after resection of colorectal liver metastasis (CLM) occurs in 50% of patients during follow-up, with 2.8% to 13.9% presenting with surgical margin recurrence (SMR). The aim of this study is to analyze factors that related to SMR in patients with CLM undergoing hepatectomy.

METHODS

Demographics, clinical and survival data of patients who underwent hepatectomy were identified from a prospectively maintained, institutional review board (IRB)-approved database between 2000 and 2012. Statistical analysis was performed using univariate Kaplan Meier and Cox proportional hazard model.

RESULTS

There were 85 female and 121 male patients who underwent liver resection for CLM. An R0 resection was performed in 157 (76%) patients and R1 resection in 49. SMR was detected in 32 patients (15.5%) followed up for a median of 29 months (range, 3-121 months). A half of these patients had undergone R1 (n=16) and another half R0 resection (n=16). Tumor size, preoperative carcinoembryonic antigen (CEA) level and margin status were associated with SMR on univariate analysis. On multivariate analysis, a positive surgical margin was the only independent predictor of SMR. The receipt of adjuvant chemotherapy did not affect margin recurrence. SMR was an independent risk factor associated with worse disease-free (DFS) and overall survival (OS).

CONCLUSIONS

This study shows that SMR, which can be detected in up to 15.5% of patients after liver resection for CLM, adversely affects DFS and OS. The fact that a positive surgical margin was the only predictive factor for SMR in these patients underscores the importance of achieving negative margins during hepatectomy.

摘要

背景

结直肠癌肝转移(CLM)切除术后肝复发在50%的患者随访期间出现,2.8%至13.9%的患者出现手术切缘复发(SMR)。本研究的目的是分析接受肝切除术的CLM患者中与SMR相关的因素。

方法

从2000年至2012年前瞻性维护、经机构审查委员会(IRB)批准的数据库中识别接受肝切除术患者的人口统计学、临床和生存数据。使用单变量Kaplan Meier和Cox比例风险模型进行统计分析。

结果

有85名女性和121名男性患者因CLM接受肝切除术。157例(76%)患者进行了R0切除,49例进行了R1切除。在32例患者(15.5%)中检测到SMR,中位随访时间为29个月(范围3 - 121个月)。这些患者中有一半接受了R1切除(n = 16),另一半接受了R0切除(n = 16)。单变量分析显示肿瘤大小、术前癌胚抗原(CEA)水平和切缘状态与SMR相关。多变量分析显示,手术切缘阳性是SMR的唯一独立预测因素。辅助化疗的使用不影响切缘复发。SMR是与无病生存期(DFS)和总生存期(OS)较差相关的独立危险因素。

结论

本研究表明,CLM肝切除术后高达15.5%的患者可检测到SMR,这对DFS和OS有不利影响。手术切缘阳性是这些患者中SMR的唯一预测因素,这一事实强调了肝切除术中实现切缘阴性的重要性。

相似文献

3
Impact of hepatectomy margin on survival following resection of colorectal metastasis: the role of adjuvant therapy and its effects.
Eur J Surg Oncol. 2013 Dec;39(12):1394-9. doi: 10.1016/j.ejso.2013.09.009. Epub 2013 Sep 14.
4
R1 Resection for Colorectal Liver Metastases: a Survey Questioning Surgeons about Its Incidence, Clinical Impact, and Management.
J Gastrointest Surg. 2018 Oct;22(10):1752-1763. doi: 10.1007/s11605-018-3820-z. Epub 2018 Jun 8.
8
Prognostic influence of hepatic margin after resection of colorectal liver metastasis: role of modern preoperative chemotherapy.
Int J Colorectal Dis. 2018 Jan;33(1):71-78. doi: 10.1007/s00384-017-2916-3. Epub 2017 Nov 2.
9
Neither Surgical Margin Status nor Somatic Mutation Predicts Local Recurrence After R0-intent Resection for Colorectal Liver Metastases.
J Gastrointest Surg. 2022 Apr;26(4):791-801. doi: 10.1007/s11605-021-05173-0. Epub 2021 Nov 1.

引用本文的文献

1
2
Peri-tumoral Metallic Implants Reduce the Efficacy of Irreversible Electroporation for the Ablation of Colorectal Liver Metastases.
Cardiovasc Intervent Radiol. 2020 Jan;43(1):84-93. doi: 10.1007/s00270-019-02300-y. Epub 2019 Aug 5.

本文引用的文献

2
Impact of hepatectomy margin on survival following resection of colorectal metastasis: the role of adjuvant therapy and its effects.
Eur J Surg Oncol. 2013 Dec;39(12):1394-9. doi: 10.1016/j.ejso.2013.09.009. Epub 2013 Sep 14.
4
Liver resection for colorectal liver metastases with peri-operative chemotherapy: oncological results of R1 resections.
HPB (Oxford). 2013 May;15(5):359-64. doi: 10.1111/j.1477-2574.2012.00581.x. Epub 2012 Oct 22.
5
Impact of complications on long-term survival after resection of colorectal liver metastases.
Br J Surg. 2013 Apr;100(5):711-8. doi: 10.1002/bjs.9060. Epub 2013 Jan 30.
6
Cancer statistics, 2013.
CA Cancer J Clin. 2013 Jan;63(1):11-30. doi: 10.3322/caac.21166. Epub 2013 Jan 17.
7
Use and dissemination of the brisbane 2000 nomenclature of liver anatomy and resections.
Ann Surg. 2013 Mar;257(3):377-82. doi: 10.1097/SLA.0b013e31825a01f6.
8
Resection margin with anatomic or nonanatomic hepatectomy for liver metastasis from colorectal cancer.
J Gastrointest Surg. 2012 Jun;16(6):1171-80. doi: 10.1007/s11605-012-1840-7. Epub 2012 Feb 28.
9
Outcome of microscopic incomplete resection (R1) of colorectal liver metastases in the era of neoadjuvant chemotherapy.
Ann Surg Oncol. 2012 May;19(5):1618-27. doi: 10.1245/s10434-011-2114-4. Epub 2011 Oct 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验